Status:
COMPLETED
Register of Patients Benefiting From a Coronary Bifurcation Angioplasty at the University Hospital of Nîmes and Montpellier in 2017
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Stent Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular diseases are the second leading cause of death in France and the world's leading cause.Coronary bifurcations are conducive to the development of atheromatous lesions due to flow turbule...
Detailed Description
Cardiovascular diseases are the second leading cause of death in France and the world's leading cause.Coronary bifurcations are conducive to the development of atheromatous lesions due to flow turbule...
Eligibility Criteria
Inclusion
- All angioplasties of bifurcation lesion to a de novo stent defined by :
- MEDINA classification 1,1,1,1 or 0,1,1,1 or 1,0,1
- Diameter of the mother and daughter branch \> 2.5mm
- No history of angioplasty of this bifurcation (de novo lesion)
- Accessible for coronary angioplasty treatment
- Patients admitted to the University Hospital of Nîmes from January 1 to December 31, 2017
Exclusion
- Minor patient
- Bifurcation lesion not meeting the above criteria
- Cardiorespiratory arrest
- Injury on bypass surgery
- Intrastent restenosis
- 2-stent angioplasty technique
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04011046
Start Date
January 1 2017
End Date
December 31 2017
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, France, 30029